Shots: Horizon to acquire Viela Bio for $53/ share, representing an equity value of $3.05B with a 53% premium over a closing price to Viela’s on Jan 29, 2020. Additionally, […]readmore
Tags : Viela Bio
Shots: Veila Bio to receive $30M upfront licensing fee, additional payment on development and commercial milestones plus royalties on sales of product post-launch MTPC to get exclusive rights to develop […]readmore